Joy Behar predicts ‘we’re all gonna die’ after new
Joy Behar predicts ‘we’re all gonna die’ after Trump transfer (Image: Getty)
On the May 19 episode of The View, Joy Behar strongly criticized businessman Mark Cuban’s new partnership tied to President Donald Trump’s prescription platform, TrumpRx, sparking a tense dialogue among the present’s co-hosts about healthcare prices and political affect.
“First of all, you lie down with dogs, you wake up with fleas,” Behar said. “Mark Cuban. I’ve always liked him, but this is a mistake. And once Trump puts his name on prescriptions, we’re all gonna die.”
TrumpRx, which launched earlier this yr, doesn’t immediately promote drugs. Instead, the platform permits customers to seek for prescribed drugs, examine pricing and entry reductions via companion companies, functioning equally to current instruments like GoodRx. The latest expansion contains more than 600 generic drugs supplied via companions such as Mark Cuban’s Cost Plus Drugs, Amazon Pharmacy and GoodRx. This comes weeks after Behar made the same prediction.
Cuban’s involvement comes despite his past criticism of Trump. His company, Mark Cuban Cost Plus Drugs, was based in 2022 with the objective of reducing prescription prices by eliminating conventional middlemen.
The company makes use of a clear pricing construction, providing drugs at the producer’s value plus a 15 p.c markup, together with a $5 labor payment and $5.25 delivery price.

Joy Behar slammed Trump’s latest RX transfer (Image: Getty)
Trump addressed the platform’s expansion on May 18, emphasizing a shared objective. “We have the same thing, one thing in common,” he said. “We want to make people better and keep them wealthy.”
Behar, however, pointed to Trump’s earlier enterprise ventures as a purpose for concern.
“He put his name on the Trump shuttle, the Trump vodka, the Trump University, Trump Hotel and my favorite, the casinos that all went bankrupt,” she said. “Don’t go there, Mark.”
The dialogue shortly was a back-and-forth among the panel. Co-host Alyssa Farah Griffin defended the platform, citing private experience with decrease medication prices.

Joy Behar is a number on The View (Image: Getty)
“The medication that I had to take for IVF is a 10th of the price on TrumpRx,” she explained. “I don’t, whatever, it’s tacky that his name is on it. Mark Cuban has dedicated his life to bringing down prescription drug costs.
“The average family, one-third of Americans, cut back on essential foods and utilities to be able to cover their prescription drug costs. You’re not going to convince me that just because Trump’s involved, we should be like, ‘Screw it,’” Griffin added.
Sunny Hostin expressed skepticism about Trump’s intentions, agreeing with Behar’s considerations. “I agree with you, Joy,” she said. “He is a failed businessman, and if you heard what he said, he said, ‘We both want to make people wealthy.’”
Griffin pushed again again, asking, “So I should pay 10 times more?”
Hostin responded, “Seemed to me that there’s something in it for him. This is not a well-intentioned president.”
Sara Haines sided with Griffin, pointing to points with prescription drug pricing in the United States. “The people that are literally suffering illnesses and cannot pay for their medicine, I can’t think of a sicker business. Bring down the prices, and if you’re going to get results on this, call it Donald Trump Medicine. I don’t care what you call it,” she said.
As the dialog continued, the panel briefly debated whether or not socialized healthcare might deal with rising prices. Behar in the end appeared to close down the dialogue. “You are so naive, the two of you,” she said.
Follow Daily Express US

Follow Daily Express US on Facebook and X (Image: EXPRESS)
Get all the latest news, leisure, sport and lifestyle updates from our devoted American team.
Sign up for our newsletters HERE.
Stay up to date with the latest happenings in the world of leisure! C-lebrity.com is your final vacation spot for trending celeb news, purple carpet highlights, film premieres, and behind-the-scenes insights from the leisure business. We carry you contemporary updates daily so that you never miss out on upcoming releases, exclusive interviews, trend tendencies, and major bulletins.
Discover how today’s largest moments are shaping the future of leisure. Visit our Top Stories part for the most participating and up-to-date showbiz coverage — from award reveals and music launches to cultural occasions and unforgettable highlights. Our rigorously curated articles are designed to maintain you informed, impressed, and entertained.
